Related references
Note: Only part of the references are listed.High-Density Lipoprotein/Apolipoprotein A-I Infusion Therapy
Jean-Claude Tardif et al.
CURRENT ATHEROSCLEROSIS REPORTS (2009)
A reconstituted HDL containing V156K or R173C apoA-I exhibited anti-inflammatory activity in apo-E deficient mice and showed resistance to myeloperoxidase-mediated oxidation
Kyung-Hyun Cho et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2009)
Synthesis of reconstituted high density lipoprotein (rHDL) containing apoA-I and apoC-III: the functional role of apoC-III in rHDL
Kyung-Hyun Cho
MOLECULES AND CELLS (2009)
The function, composition, and particle size of high-density lipoprotein were severely impaired in an oliguric phase of hemorrhagic fever with renal syndrome patients
Kyung-Hyun Cho et al.
CLINICAL BIOCHEMISTRY (2008)
Effects of reconstituted high-density lipoprotein infusions on coronary atherosclerosis -: A randomized controlled trial
Jean-Claude Tardif et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2007)
A Caucasian male with very low blood cholesterol and low apoA-II without evidence of atherosclerosis
S. H. Park et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2007)
ApoA-I mutants V156K and R173C promote anti-inflammatory function and antioxidant activities
K. H. Cho et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2006)
Paraoxonase and arylesterase activities in coronary artery disease
M. Gur et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2006)
Reconstituted high density lipoprotein enriched with the polyene antibiotic amphotericin B
MN Oda et al.
JOURNAL OF LIPID RESEARCH (2006)
Polymorphisms in the PON gene cluster are associated with Alzheimer disease
PM Erlich et al.
HUMAN MOLECULAR GENETICS (2006)
C-reactive protein, interleukin-6, and soluble adhesion molecules as predictors of progressive peripheral atherosclerosis in the general population - Edinburgh Artery Study
I Tzoulaki et al.
CIRCULATION (2005)
Emerging role of high-density lipoprotein in the prevention of cardiovascular disease
ME Brousseau
DRUG DISCOVERY TODAY (2005)
New insights into the regulation of HDL metabolism and reverse cholesterol transport
GF Lewis et al.
CIRCULATION RESEARCH (2005)
Structural and functional properties of V156K and A158E mutants of apolipoprotein A-I in the lipid-free and lipid-bound states
JM Han et al.
JOURNAL OF LIPID RESEARCH (2005)
High-density lipoproteins reduce the effect of endotoxin on cytokine production and systemic hemodynamics in cirrhotic rats with ascites
MJ Ramírez et al.
JOURNAL OF HEPATOLOGY (2004)
Human apolipoprotein A-I and A-I mimetic peptides: potential for atherosclerosis reversal
M Navab et al.
CURRENT OPINION IN LIPIDOLOGY (2004)
Human apolipoprotein A-II enrichment displaces paraoxonase from HDL and impairs its antioxidant properties -: A new mechanism linking HDL protein composition and antiatherogenic potential
V Ribas et al.
CIRCULATION RESEARCH (2004)
Antiinflammatory properties of HDL
PJ Barter et al.
CIRCULATION RESEARCH (2004)
Reconstituted high-density lipoprotein exhibits neuroprotection in two rat models of stroke
R Paterno et al.
CEREBROVASCULAR DISEASES (2004)
Inflammatory markers and onset of cardiovascular events - Results from the Health ABC study
M Cesari et al.
CIRCULATION (2003)
Importance of different pathways of cellular cholesterol efflux
PG Yancey et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2003)
HDL apolipoproteins and ABCA1 - Partners in the removal of excess cellular cholesterol
JF Oram
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2003)
Cholesteryl ester transfer protein - A novel target for raising HDL and inhibiting atherosclerosis
PJ Barter et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2003)
Reconstituted high-density lipoprotein attenuates organ injury and adhesion molecule expression in a rodent model of endotoxic shock
MC McDonald et al.
SHOCK (2003)
Opposite effects of plasma from human apolipoprotein A-II transgenic mice on cholesterol efflux from J774 macrophages and Fu5AH hepatoma cells
N Fournier et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2002)
Apolipoprotein A-IMilano and apolipoprotein A-IParis exhibit an antioxidant activity distinct from that of wild-type apolipoprotein A-I
JK Bielicki et al.
BIOCHEMISTRY (2002)
Apolipoproteins C-I and C-III as important modulators of lipoprotein metabolism
NS Shachter
CURRENT OPINION IN LIPIDOLOGY (2001)
Share Paper
